Literature DB >> 25636937

Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012).

S Monge1, M Díez2, M Alvarez3, V Guillot3, J A Iribarren4, R Palacios5, R Delgado6, A Jaén7, J R Blanco8, P Domingo9, J Portilla10, M J Pérez Elías11, F Garcia3.   

Abstract

Prevalence of transmitted drug resistance (pTDR) to antiretroviral drugs in Spain (2007-2012) was estimated using the CoRIS cohort, adjusting its territorial distribution and transmission route to the reference population from the Spanish Information System on New human immunodeficiency virus diagnoses. A total of 2702 patients from ten autonomous communities and with naive FASTA sequence within 6 months of human immunodeficiency virus diagnosis were selected. Weighted pTDR, estimated using the inverse probability of selection in the sample by autonomous communities and transmission group, was 8.12% (95% CI 6.44-9.80), not significantly different from unweighted pTDR. We illustrate how proportional weighting can maximize representativeness of cohort-based data, and its value to monitor pTDR at country level.
Copyright © 2014 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antiretroviral agents; cohort studies; drug resistance; epidemiological monitoring; human immunodeficiency virus

Mesh:

Substances:

Year:  2014        PMID: 25636937     DOI: 10.1016/j.cmi.2014.08.007

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  1 in total

1.  Are European HIV cohort data within EuroCoord representative of the diagnosed HIV population?

Authors:  Georgia Vourli; Anastasia Pharris; Francoise Cazein; Dominique Costagliola; Francois Dabis; Julia Del Amo; Valerie Delpech; Asuncion Díaz; Enrico Girardi; Annabelle Gourlay; Barbara Gunsenheimer-Bartmeyer; Victoria Hernando; Georgios Nikolopoulos; Kholoud Porter; Magdalena Rosińska; Caroline Sabin; Barbara Suligoi; Virginie Supervie; Ferdinand Wit; Giota Touloumi
Journal:  AIDS       Date:  2019-01-27       Impact factor: 4.177

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.